Drugs / TDF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06061536 Background | Nov 2023 → Nov 2024 | HIV infectious disease | Shanxi Kangbao Biological Product Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDF | “Lipovirtide 10mg+3TC+TDF（LP-80：once a week；3TC+TDF：once daily）” NCT06061536 ↗ |